NVP Associates, LLC — 13F Holdings & Portfolio
CIK 1545692 · latest 13F-HR filed 2026-05-15
NVP Associates, LLC manages $176.2M in 13F-reported U.S. long-equity assets across 5 reported positions as of its 2026-03-31 13F-HR filing. Its largest disclosed positions are MBX (36.20%), BLLN (23.00%), ZBIO (20.40%). Quarter over quarter (versus its 2025-12-31 filing) the fund opened 0 new positions, exited 1, added to 1, and trimmed 3.
AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.
$176.2M
Long-equity book
5
Distinct positions
2026-03-31
Filed 2026-05-15
+0 / −1 / ↑1 / ↓3
vs 2025-12-31
| Name | Title / Status | Ownership | Type |
|---|
Top Trims
- ZENAS BIOPHARMA INC-$30.8M -46.2%
- OMADA HEALTH INC-$8.1M -20.3%
- MBX BIOSCIENCES INC-$3.6M -5.4%
Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).
| # | Issuer | Symbol | CUSIP | Value | Weight | Shares | Type |
|---|---|---|---|---|---|---|---|
| 1 | MBX BIOSCIENCES INC | MBX | 55287L101 | $63.8M | 36.20% | 2,136,335 | SH |
| 2 | BILLIONTOONE INC | BLLN | 090168105 | $40.5M | 23.00% | 513,330 | SH |
| 3 | ZENAS BIOPHARMA INC | ZBIO | 98937L105 | $35.9M | 20.40% | 1,838,482 | SH |
| 4 | OMADA HEALTH INC | OMDA | 68170A108 | $31.8M | 18.06% | 2,531,000 | SH |
| 5 | GROVE COLLABORATIVE HOLD INC | GROV | 39957D201 | $4.1M | 2.34% | 3,225,097 | SH |
| Period | Filed | AUM | Holdings | Accession |
|---|---|---|---|---|
| 2026-03-31 | 2026-05-15 | $176.2M | 5 | 0001545692-26-000005 |
| 2025-12-31 | 2026-02-17 | $255.2M | 6 | 0001545692-26-000002 |
| 2025-09-30 | 2025-11-14 | $166.1M | 5 | 0001545692-25-000005 |